Výsledky vyhledávání

Stool for fecal microbiota transplantation should be classified as a transplant product and not as a drug

Autor: Keller, J.J., Vehreschild, M.J.G.T., Hvas, C.L., Jorgensen, S.M.D., Kupciskas, J., Link, A., Mulder, C.J.J., Goldenberg, S.D., Arasaradnam, R., Sokol, H., Gasbarrini, A., Hoegenauer, C., Terveer, E.M., Kuijper, E.J., Arkkila, P., Gridnyev, O., Megraud, F., Kump, P.K., Nakov, R., Satokari, R., Tkatch, S., Sanguinetti, M., Cammarota, G., Dorofeev, A., Gubska, O., Ianiro, G., Mattila, E., Ooijevaar, R.E., Sarin, S.K., Sood, A., Putignani, L., Alric, L., Williams, H.R.T., Goorhuis, A., Verspaget, H.W., Hold, G.L., Tilg, H., Ponsioen, C.Y., Standards Guidelines Initiative

Publikováno v: United European Gastroenterology Journal
United European Gastroenterology Journal, SAGE Publications, 2019, 7 (10), pp.1408-1410. ⟨10.1177/2050640619887579⟩
Keller, J J, Vehreschild, M J GT, Hvas, C L, Jørgensen, S M D, Kupciskas, J, Link, A, Mulder, C J J, Goldenberg, S D, Arasaradnam, R, Sokol, H, Gasbarrini, A, Hoegenauer, C, Terveer, E M, Kuijper, E J, Arkkila, P & On behalf of the UEG working group of the Standards and Guidelines initiative Stool banking for FMT 2019, ' Stool for fecal microbiota transplantation should be classified as a transplant product and not as a drug ', United European Gastroenterology Journal, vol. 7, no. 10, pp. 1408-1410 . https://doi.org/10.1177/2050640619887579
United European Gastroenterol J
United European Gastroenterology Journal, 7(10), 1408-1410. SAGE Publications Inc.
Keller, J J, Vehreschild, M JGT, Hvas, C L, Jørgensen, S MD, Kupciskas, J, Link, A, Mulder, C JJ, Goldenberg, S D, Arasaradnam, R, Sokol, H, Gasbarrini, A, Hoegenauer, C, Terveer, E M, Kuijper, E J & Arkkila, P 2019, ' Stool for fecal microbiota transplantation should be classified as a transplant product and not as a drug ', United European Gastroenterology Journal, vol. 7, no. 10, pp. 1408-1410 . https://doi.org/10.1177/2050640619887579

International audience; Fecal microbiota transplantation (FMT) or donor feces infusion is a therapy that aims to restore a perturbed gut microbiota composition and function. FMT is effective for treatment of patients with (multiple) recurrent Clostri

Vyhledávací nástroje:

Upřesnit hledání